[2024]

200. Yoon S, Lee S, Kim H*, Song J, Baek M, Ryu S, Lee H, Moon H, Noh D, Jon S, Han H*. NSDHL contributes to breast cancer stem-like cell maintenance and tumor-initiating capacity through TGF-β/Smad signaling pathway in MCF-7 tumor spheroid. BMC Cancer. 2024. 24. 1370.

199. Guo Z, Saw PE, Jon S*. Non-Invasive Physical Stimulation to Modulate the Tumor Microenvironment: Unveiling a New Frontier in Cancer Therapy. BIO Integration. 2024. Vol. 5(1)

198. Jung W, Asaduddin M, Yoo D, Lee D, Son Y, Kim D, Keum H, Lee J, Park S*, Jon S*. Noninvasive ROS imaging and drug delivery monitoring in the tumor microenvironment. Biomaterials​. 2024, 310, 122633.

197. Kim D, Whang C, Hong J, Prayogo M, Jung W, Lee S, Shin H, Kim Y, Yu J, Kim M, Kim K, Lee H*, Jon S*. Glycocalyx-Mimicking Nanoparticles with Differential Organ Selectivity for Drug Delivery and Therapy. Advanced Materials​. 2024, 2311283.

196. Jung W, Asaduddin M, Keum H, Son Y, Yoo D, Kim D, Lee S, Lee D, Roh J, Park S* and ​Jon S​*. Longitudinal Magnetic Resonance Imaging with ROS-Responsive Bilirubin Nanoparticles Enables Monitoring of Non-Alcoholic Steatohepatitis Progression to Cirrhosis. ​Advanced Materials​. 2024, 2305830. 

195. Kim T, Whang C, ​Kim D​, and ​Jon S​*. Prodrug Celecoxib-Derived Nanoparticles Potentiate the Efficacy of Cancer Immunotherapy by Remodeling the Tumor Microenvironment. ​Advanced Therapeutics​. 2024, 2300321.

[2023]

194. Kim Y, ​Lee S​, and ​Jon S​*. Liposomal Delivery of an Immunostimulatory CpG Induces Robust Antitumor Immunity and Long-Term Immune Memory by Reprogramming Tumor-Associated Macrophages. ​Advanced Healthcare Materials​. 2023, 2300549.

193. Ryu S, Yoon S, ​Song J​, Choi Y, Lee S, Baek M, Lee H, Jeon S, ​Jon S​, Lee D, Kim H*, and Han W*. Impact of media compositions and culture systems on the immunephenotypes of patient-derived breast cancer cells. ​BMC Cancer​. 2023, 23, 831.

192. ​Yoo D​, Whang C, Hong J, Kim D, ​Prayogo M C​, Son Y, Jung W, Lee S, Lee H*, and ​Jon S​*. Anti-inflammatory glycocalyx-mimicking nanoparticles for colitis treatment: Construction and in vivo evaluation. ​Angewandte Chemie​. 2023, e202304815.

191. ​Rahman A T​,​ ​Shin J, Whang C, Jung W, Yoo D, Seo C, Cho B*, and Jon S*. Bilirubin nanomedicine rescues intestinal barrier destruction and restores mucosal immunity in colitis. ACS Nano. 2023, 17(11), 10996-11013.

190. Shin H, Kim Y, and Jon S*. Nanovaccine displaying immunodominant T cell epitopes of fibroblast activation protein is effective against desmoplastic tumors. ACS Nano. 2023, 17(11), 10337-10352.

​ 

[2022]

189. Choi C, Keum H, Yang S, Kang B, Kim D, Piao H, Kim J, Kim B, Youn S*, Jon S*. Bilirubin Nanomedicine Alleviates Inflammation and Angiogenesis in a Rosacea Mouse Model. Advanced Therapeutics. 2022, 2200223.

188. Jung W, Lee D, Moon E, Jon S*. Nanoparticles Derived from Naturally Occurring Metal Chelators for Theranostic Applications. ADDR. 2022, 191, 114620.

187. See S, Hong N, Song J, Kim D, Choi Y, Lee D, Jon S, H Kim. Polymer Thin Film Promotes Tumor Spheroid Formation via JAK2-STAT3 Signaling Primed by Fibronectin-Integrin α5 and Sustained by LMO2-LDB1 Complex. Biomedicines. 2022, 10(11), 2684.

186. Kim T, Kim Y, Keum H, Jung W, Kang M, Jon S. Combination of a STAT3 Inhibitor with Anti-PD-1 Immunotherapy is an Effective Treatment Regimen for a Vemurafenib-Resistant Melanoma. Molecular Therapy-Oncolytics. 2022, 26, 1-14.

185. Whang C, Hong J, Ryu H, Jung W, Son Y, Keum H, Kim J, Shin H, Moon E, Noh I, Lee H, Jon S*. Systematic Screening and Therapeutic Evaluation of Glyconanoparticles with Differential Cancer Affinities for Targeted Cancer Therapy. Advanced Materials. 2022, 34(30), 2203993.

184. Pareek S, Flegle AS, Boagni D, Kim J, Yoo D, Trujillo-Ocampo A, Zhang M, Jon S and Im J*. Post Transplantation Bilirubin Nanoparticles Ameliorate Murine Graft Versus Host Disease via a Reduction of Systemic and Local Inflammation. Front. Immunol. 2022; 13, 893659.

183. Park H, Jeon H, Cha H, Bang J, Song Y, Choi M, Sung D, Choi W, Lee J, Woo J, Jon S*, Kim S*. Purification of Therapeutic Antibodies Using the Ca²⁺-Dependent Phase-Transition Properties of Calsequestrin. Analytical chemistry. 2022, 94(15), 5875-5882.

182. Keum H, Kim D, Whang C, Kang A, Lee S, Na W, Jon S*. Impeding the Medical Protective Clothing Contamination by a Spray Coating of Trifunctional Polymers. ACS omega. 2022, 7(12), 10526-10538.

181. Yu B, Yoo D, Kim K, Kim T, Park S, Kim Y, Son Y, Kim J, Noh I, Whang C, Chung J, Jon S*. Effective Combination Immunotherapy through Vessel Normalization Using a Cancer‐Targeting Antiangiogenic Peptide–Antibody Hybrid. Advanced Therapeutics. 2022, 5(4), 2100151.

180. Keum H, Yoo D, Jon S*. Photomedicine Based on Heme-Derived Compounds. ADDR. 2022, 182, 114134.

[2021]

179. Ai W, Bae S, Ke Q, Su S, Li R, Chen Y, Yoo D, Lee E, Jon S, Kang P*. Bilirubin Nanoparticles Protect Against Cardiac Ischemia/Reperfusion Injury in Mice. J. Am. Heart Assoc. 2021, 10(20), e021212.

178. Saw PE, Xu X, Kim S, Jon S*. Biomedical Applications of a Novel Class of High-Affinity Peptides. Acc. Chem. Res. 2021, 54(18), 3576-3592.

177. Keum H, Kim D, Kim J, Kim T, Whang C, Jung W, Jon S*. A Bilirubin-Derived Nanomedicine Attenuates the Pathological Cascade of Pulmonary Fibrosis. Biomaterials. 2021, 275, 120986.

176. Kang S, Kim Y, Shin Y, Song J, Jon S*. Antigen-Presenting, Self-Assembled Protein Nanobarrels as an Adjuvant-Free Vaccine Platform against Influenza Virus. ACS Nano. 2021, 15(6), 10722-10732.

175. Noh I, Son Y, Jung W, Kim M, Kim D, Shin H, Kim Y, Jon S*. Targeting the Tumor Microenvironment with Amphiphilic Near-Infrared Cyanine Nanoparticles for Potentiated Photothermal Immunotherapy. Biomaterials. 2021, 275, 120926.

174. Keum H, Kim J, Yoo D, Kim T, Seo C, Kim D, Jon S*. Biomimetic Lipid Nanocomplexes Incorporating STAT3-Inhibiting Peptides Effectively Infiltrate the Lung Barrier and Ameliorate Pulmonary Fibrosis. JCR. 2021, 332, 160-170.

173. Ichzan AM, Hwang S, Cho H, San Fang C, Park S, Kim G, Kim J, Nandhakumar P, Yu B, Jon S, Kim K, Yang H. Solid-Phase Recombinase Polymerase Amplification Using an Extremely Low Concentration of a Solution Primer for Sensitive Electrochemical Detection of Hepatitis B Viral DNA. Biosensors and Bioelectronics. 2021, 179, 113065.

172. Bhatia A, Na H, Nandhakumar P, Yu B, Jon S, Chung J *, Yang H *. Electrochemical Detection of Interleukin-8 in Human Saliva Using a Polyenzyme Label Based on Diaphorase and Neutravidin. Sensors and Actuators B: Chemical. 2021, 326, 128979.

171. Yoo D, Jung W, Son Y, S Jon*. Glutathione-Responsive Gold Nanoparticles as Computed Tomography Contrast Agents for Hepatic Diseases. ACS Applied Bio Materials. 2021, 4(5), 4486-4494.

170. Kim T, Kim Y, Jung W, Kim D, Keum H, Son Y, Jon S*. Bilirubin Nanomedicine Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis by Modulating Dendritic Cells. JCR. 2021, 331, 74-84.

169. Saw PE, Xu X, Kang B, Choi C, Jon S, Chong K*. Extra-Domain B of Fibronectin as an Alternative Target for Drug Delivery and a Cancer Diagnostic and Prognostic Biomarker for Malignant Glioma. Theranostics. 2021, 11(2), 941-957.

[2020]

168. Hwang K, Seo Y, Kim D, Ahn J, Lee S, Han K, Lee K, Jon S, Kim P, Yu K, Kim H, Kang S and Jeong K*. Handheld Endomicroscope Using a Fiber-Optic Harmonograph Enables Real-Time and In Vivo Confocal Imaging of Living Cell Morphology and Capillary Perfusion. Microsystems and Nanoengineering. 2020, 6, 72.

167. H Keum, Kim T, Kim Y, Seo C, Son Y, Kim J, Kim D, Jung W, Whang C, Jon S*. Bilirubin Nanomedicine Alleviates Psoriatic Skin Inflammation by Reducing Oxidative Stress and Suppressing Pathogenic Signaling. JCR. 2020, 325(10), 359-369.

166. Kim J, Lee J, Lee J, Keum H, Kim Y, Kim Y, Yu B, Lee S, Tanaka J, Jon S*, Choi M*. Tubulin-Based Nanotubes as Delivery Platform for Microtubule-Targeting Agents. Adv. Mater. 2020, 32(33), e202002902.

165. Chung C, Jung W, Keum H, Kim T, Jon S*. Nanoparticles Derived From the Natural Antioxidant, Rosmarinic Acid, Ameliorate Acute Inflammatory Bowel Disease. ACS Nano. 2020, 14(6), 6887-6896.

164. Kim Y, Kang S, Shin H, Kim T, Yu B, Kim J, Yoo D, Jon S*. Sequential and Timely Combination of Cancer Nanovaccine with Immune Checkpoint Blockade Effectively Inhibits Tumor Growth and Relapse. Angew. Chem. Int. Ed. 2020, 59(34), 14628-14638.

163. Lee D, Kang S, Lee Y, Kim J, Yoo D, Jung W, Lee S, Jeong Y, Lee K, Jon S*. PEGylated Bilirubin-Coated Iron Oxide Nanoparticles as a Biosensor for Magnetic Relaxation Switching-Based ROS Detection in Whole Blood. Theranostics. 2020, 10(5), 1997.

162. Kim J, Keum H, Kim H, Yu B, Jung W, Whang C, Seo C, Park J, Jon S*. Gold Nanorods with an Ultrathin Anti-Biofouling Siloxane Layer for Combinatorial Anticancer Therapy. J. Drug Target. 2020, 28(7-8), 780-788.

161. Haque AMJ, Nandhakumar P, Kim G, Park S, Yu B, Lee N, Yoon Y, Jon S, Yang H*. Diaphorase-Catalyzed Formation of a Formazan Precipitate and Its Electrodissolution for Sensitive Affinity Biosensors. Anal. Chem. 2020, 92, 5, 3932-3939.

160. Noh I, Kim M, Kim J, Lee D, Oh D, Kim C, Jon S, Kim Y*. Structure-Inherent Near-Infrared Bilayer Nanovesicles for use as Photoacoustic Image-Guided Chemo-Thermotherapy. J. Control. Release​. 2020, 320, 283-292.

159. Yang J, Park C, Kim S, Noh T, Kim J, Park S, Lee J, Park J, Yoo D, Jung H, Takase H, Shima DT, Schwaninger M, Lee S, Kim I, Lee J, Ji Y, Jon S, Oh W, Kim P, Uemura A, Ju Y and Kim I*. DII4 Suppress Transcytosis for Arterial Blood-Retinal Barrier Homeostasis. Circ. Res. 2020, 126(6), 767-783.

[2019]

158. Lee Y, Sugihara K, Gillilland MG, Jon S, Kamada N, Moon J. Hyaluronic Acid-Bilirubin Nanomedicine for Targeted Modulation of Dysregulated Intestinal Barrier, Microbiome and Immune Responses in Colitis. Nat. Mater. 2020, 19, 118-126.

157. Yoo J, Rejinold NS, Lee D, Noh I, Koh W, Jon S, Kim Y*. CD44-Mediated Methotrexate Delivery by Hyaluronan Coated Nanoparticles Composed of a Branched Cell-Penetrating Peptide. ACS Biomater. Sci. Eng. 2020, 6, 1, 494-504.

156. Jeong C, Noh I, Rejinold NS, Kim J, Jon S, Kim Y*. Self-Assembled Supramolecular Bilayer Nanoparticles Composed of Near-Infrared Dye as a Theranostic Nanoplatform to Encapsulate Hydrophilic Drugs Effectively. ACS Biomater. Sci. Eng. 2020, 6, 1, 474-484.

155. Saw PE*, Lee S, Jon S*. Naturally Occurring Bioactive Compound-Derived Nanoparticles for Biomedical Applications. Adv. Therap. 2019, 2, 1800146.

154. Kim D, Hwang K, Ahn J, Seo Y, Kim J, Lee S, Yoon J, Kong E, Jeong Y, Jon S, Kim P and Jeong K*. Lissajous Scanning Two-Photon Endomicroscope for In Vivo Tissue Imaging. Sci. Rep. 2019, 9(1), 3560.

153. Yu B, Hwang D, Jeon H, Kim H, Lee Y, Keum H, Kim J, Lee D, Kim Y, Chung J and Jon S*. A Hybrid Platform Based on a Bispecific Peptide-Antibody Complex for Targeted Cancer Therapy. Angew. Chem. Int. Ed. 2019, 58(7), 2005-2010.

152. Kim H, Hwang D, Choi M, Lee S, Kang S, Lee Y, Kim S, Chung J* and Jon S*. Antibody-Assisted Delivery of a Peptide-Drug Conjugate for Targeted Cancer Therapy. Mol. Pharm. 2019, 16(1), 165-172.